Healthcare Equipment and Supplies
Company Overview of ZOLL Medical Corporation
ZOLL Medical Corporation develops and markets medical devices. The company offers defibrillators and monitors, ventilators and aspirators, automated external defibrillators, temperature management systems, fluid resuscitation solutions, and electrodes and batteries. Additionally, it develops medical software. The company also provides customer and technical support solutions. It focuses on healthcare, public safety, military, homeland security, and alternate care. The company was founded in 1980 and is based in Chelmsford, Massachusetts. ZOLL Medical Corporation operates as a subsidiary of Asahi Kasei Corporation.
269 Mill Road
Chelmsford, MA 01824
Founded in 1980
Key Executives for ZOLL Medical Corporation
Senior Vice President of International Operations
Senior Vice President and Vice President of North American Sales
President of ZOLL Data Management Products
President of ZOLL Core Products
Compensation as of Fiscal Year 2015.
ZOLL Medical Corporation Key Developments
ZOLL Medical Corporation Announces New ResQCPR System
Oct 8 15
ZOLL Medical Corporation announced that its new ResQCPR™ System, which offers new hope for survival from sudden cardiac arrest (SCA), is now available nationwide. Instances of the ResQCPR System helping to save lives are already being reported by early adopters of the technology. The ResQCPR System is a combination of two medical devices, the ResQPUMP® ACD-CPR device and the ResQPOD® Impedance Threshold Device (ITD). The devices are used together during CPR to create an enhanced vacuum in the chest that improves blood flow to the brain and vital organs during states of low blood flow such as cardiac arrest. The device combination was shown in a large clinical trial to improve survival to one year from out-of-hospital, non-traumatic cardiac arrest by 49% when compared to treatment with conventional cardiopulmonary resuscitation (CPR).According to the Food and Drug Administration (FDA), the ResQCPR System is the first and only CPR device indicated to improve the likelihood of survival in adults who have experienced non-traumatic sudden cardiac arrest.
Baku 2015 Equips European Games with ZOLL AED Plus to Treat Sudden Cardiac Arrest
Jun 12 15
ZOLL Medical Corporation announced that the Baku 2015 European Games, being held 12-28 June in Baku, Azerbaijan, will be equipped with the ZOLL AED Plus in the event that anyone attending or participating in this inaugural edition of the European Games experiences a sudden cardiac arrest. Eighty AED Plus units will be distributed among the mobile medical teams and be available across all Baku 2015 venues. According to the Operations Committee of the Baku Games, the AED Plus was recommended because of its CPR feedback technology. In addition to providing a shock if needed, the AED Plus features Real CPR Help technology, real-time audio and visual feedback to guide rescuers to the correct depth and rate of chest compression to deliver high-quality CPR and positively impact outcomes.
Opto Circuits Wins $23 Million in a Case Against Zoll
Jun 8 15
Opto Circuits (India) Ltd. has informed in a filing to BSE that its group company Cardiac Science Corporation has won a long-standing dispute over the company's wearable defibrillator technology. A 12-person jury in Los Angeles Superior Court has unanimously decided in favour of the company's breach of contract claims against Zoll Medical Corporation, and Zoll LifeCor Corporation, awarding Cardiac Science USD 22,991,985 in lost royalties. The dispute relates to the company's patented wearable defibrillator technology. In 2002, LifeCor began marketing its LifeVest product, which infringed a number of Cardiac Science's patents. To avoid infringement claims, LifeCor entered into a cross-license agreement with Cardiac Science and was able to continue selling its device.
Similar Private Companies By Industry
Recent Private Companies Transactions